Tenvie Therapeutics is a biotechnology company dedicated to developing small-molecule therapies for central nervous system (CNS) disorders. Led by President and Chief Scientific Officer Tony Estrada, a co-founder who previously served as Senior Vice President and Head of Discovery Sciences at Denali Therapeutics, the leadership team includes Chief Business and Legal Officer Brian Cuneo, Chief Medical Officer Dr. Tanya Fischer, and Vice President of Human Resources and Operations Sulynn Barnes. Together, they bring extensive experience in drug development, business strategy, clinical research, and organizational management to advance Tenvie's mission of improving the lives of patients and caregivers affected by neurological conditions.